Provider: Nature Publishing Group Content: application/x-research-info-systems TY - JOUR AU - Klausner, R. D. TI - Medicine. The need for a global HIV vaccine enterprise JA - Science PY - 2003/// VL - 300 SP - 2036 EP - 2069 M3 - 10.1126/science.1086916 N1 - 10.1126/science.1086916 UR - http://dx.doi.org/10.1126/science.1086916 ER - TY - JOUR AU - Shattock, R. A. AU - Moore, J. P. TI - Inhibiting HIV-1 sexual transmission JA - Nature Rev. Microbiol. PY - 2003/// VL - 1 SP - 25 EP - 34 M3 - 10.1038/nrmicro729 N1 - 10.1038/nrmicro729 UR - http://dx.doi.org/10.1038/nrmicro729 ER - TY - JOUR AU - Lin, P. F. TI - A small molecule HIV-1 inhibitor that targets the HIV-1 envelope and inhibits CD4 receptor binding JA - Proc. Natl Acad. Sci. USA PY - 2003/// VL - 100 SP - 11013 EP - 11018 M3 - 10.1073/pnas.1832214100 N1 - 10.1073/pnas.1832214100 UR - http://dx.doi.org/10.1073/pnas.1832214100 ER - TY - JOUR AU - Guo, Q. TI - Biochemical and genetic characterizations of a novel human immunodeficiency virus type 1 inhibitor that blocks gp120-CD4 interactions JA - J. Virol. PY - 2003/// VL - 77 SP - 10528 EP - 10536 M3 - 10.1128/JVI.77.19.10528-10536.2003 N1 - 10.1128/JVI.77.19.10528-10536.2003 UR - http://dx.doi.org/10.1128/JVI.77.19.10528-10536.2003 ER - TY - JOUR AU - Shen, D. M. TI - Antagonists of human CCR5 receptor containing 4-(pyrazolyl)piperidine side chains. Part 2: Discovery of potent, selective, and orally bioavailable compounds JA - Bioorg. Med. Chem. Lett. PY - 2004/// VL - 14 SP - 941 EP - 945 M3 - 10.1016/j.bmcl.2003.12.005 N1 - 10.1016/j.bmcl.2003.12.005 UR - http://dx.doi.org/10.1016/j.bmcl.2003.12.005 ER - TY - GEN TI - ER - TY - JOUR AU - Seibert, C. AU - Sakmar, T. P. TI - Small-molecule antagonists of CCR5 and CXCR4: A promising new class of anti-HIV-1 drugs JA - Curr. Pharmacol. Des. PY - 2004/// VL - 10 SP - 2041 EP - 2062 ER - TY - JOUR AU - Veazey, R. S. TI - Use of a small-molecule CCR5 inhibitor in macaques to treat simian immunodeficiency virus infection and prevent simian-human immunodeficiency virus infection JA - J. Exp. Med. PY - 2003/// VL - 198 SP - 1551 EP - 1562 M3 - 10.1084/jem.20031266 N1 - 10.1084/jem.20031266 UR - http://dx.doi.org/10.1084/jem.20031266 ER - TY - JOUR AU - Wolinsky, S. M. TI - Effect of a CCR5 inhibitor on viral loads in macaques dual-infected with R5 and X4 primate immunodeficiency viruses JA - Virology PY - 2004/// VL - 328 SP - 19 EP - 29 M3 - 10.1016/j.virol.2004.07.021 N1 - 10.1016/j.virol.2004.07.021 UR - http://dx.doi.org/10.1016/j.virol.2004.07.021 ER - TY - GEN TI - ER - TY - JOUR AU - Matthews, T. TI - Enfuvirtide: The first therapy to inhibit the entry of HIV-1 into host CD4 lymphocytes JA - Nature Rev. Drug Disc. PY - 2004/// VL - 3 SP - 215 EP - 221 ER - TY - JOUR AU - Harouse, J. M. TI - Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3 JA - J. Virol. PY - 2001/// VL - 75 SP - 1990 EP - 1995 M3 - 10.1128/JVI.75.4.1990-1995.2001 N1 - 10.1128/JVI.75.4.1990-1995.2001 UR - http://dx.doi.org/10.1128/JVI.75.4.1990-1995.2001 ER - TY - JOUR AU - Moore, J. P. AU - Kitchen, S. G. AU - Pugach, P. AU - Zack, J. A. TI - The CCR5 and CXCR4 coreceptors[mdash]central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection JA - AIDS Res. Hum. Retroviruses PY - 2004/// VL - 20 SP - 111 EP - 126 M3 - 10.1089/088922204322749567 N1 - 10.1089/088922204322749567 UR - http://dx.doi.org/10.1089/088922204322749567 ER - TY - JOUR AU - Veazey, R. S. TI - Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120 JA - Nature Med. PY - 2003/// VL - 9 SP - 343 EP - 346 M3 - 10.1038/nm833 N1 - 10.1038/nm833 UR - http://dx.doi.org/10.1038/nm833 ER - TY - JOUR AU - Lederman, M. M. TI - Prevention of vaginal SHIV transmission in rhesus macaques through inhibition of CCR5 JA - Science PY - 2004/// VL - 306 SP - 485 EP - 487 M3 - 10.1126/science.1099288 N1 - 10.1126/science.1099288 UR - http://dx.doi.org/10.1126/science.1099288 ER - TY - JOUR AU - Tsai, C. C. TI - Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models JA - AIDS Res. Hum. Retroviruses PY - 2004/// VL - 20 SP - 11 EP - 18 M3 - 10.1089/088922204322749459 N1 - 10.1089/088922204322749459 UR - http://dx.doi.org/10.1089/088922204322749459 ER - TY - JOUR AU - Hu, Q. TI - Blockade of attachment and fusion receptors inhibits HIV-1 infection of human cervical tissue JA - J. Exp. Med. PY - 2004/// VL - 199 SP - 1065 EP - 1075 M3 - 10.1084/jem.20022212 N1 - 10.1084/jem.20022212 UR - http://dx.doi.org/10.1084/jem.20022212 ER - TY - JOUR AU - Tremblay, C. TI - Effects of HIV-1 entry inhibitors in combination JA - Curr. Pharm. Des. PY - 2004/// VL - 10 SP - 1861 EP - 1865 M3 - 10.2174/1381612043384501 N1 - 10.2174/1381612043384501 UR - http://dx.doi.org/10.2174/1381612043384501 ER - TY - JOUR AU - Watson, C. AU - Jenkinson, S. AU - Kazmierski, W. AU - Kenakin, T. P. TI - The CCR5 receptor-based mechanism of action of 873140, a potent allosteric non-competitive HIV entry-inhibitor JA - Mol. Pharmacol. PY - 2005/// VL - 67 SP - 1268 EP - 1282 M3 - 10.1124/mol.104.008565 N1 - 10.1124/mol.104.008565 UR - http://dx.doi.org/10.1124/mol.104.008565 ER - TY - GEN TI - ER - TY - JOUR AU - Marx, P. A. TI - Progesterone implants enhance SIV vaginal transmission and early virus load JA - Nature Med. PY - 1996/// VL - 2 SP - 1084 EP - 1089 M3 - 10.1038/nm1096-1084 N1 - 10.1038/nm1096-1084 UR - http://dx.doi.org/10.1038/nm1096-1084 ER - TY - JOUR AU - Otten, R. A. TI - Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates JA - J. Infect. Dis. PY - 2005/// VL - 191 SP - 164 EP - 173 M3 - 10.1086/426452 N1 - 10.1086/426452 UR - http://dx.doi.org/10.1086/426452 ER - TY - JOUR AU - Dyer, J. R. TI - High levels of human immunodeficiency virus type 1 in blood and semen of seropositive men in sub-Saharan Africa JA - J. Infect. Dis. PY - 1998/// VL - 177 SP - 1742 EP - 1746 ER - TY - JOUR AU - Wawer, M. J. TI - Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda JA - J. Infect. Dis. PY - 2005/// VL - 191 SP - 1403 EP - 1409 M3 - 10.1086/429411 N1 - 10.1086/429411 UR - http://dx.doi.org/10.1086/429411 ER - TY - JOUR AU - Reeves, J. D. TI - Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics JA - Proc. Natl Acad. Sci. USA PY - 2002/// VL - 99 SP - 16249 EP - 16254 M3 - 10.1073/pnas.252469399 N1 - 10.1073/pnas.252469399 UR - http://dx.doi.org/10.1073/pnas.252469399 ER - TY - JOUR AU - Miller, C. J. TI - Propagation and dissemination of infection after vaginal transmission of simian immunodeficiency virus JA - J. Virol. PY - 2005/// VL - 79 SP - 9217 EP - 9227 M3 - 10.1128/JVI.79.14.9217-9227.2005 N1 - 10.1128/JVI.79.14.9217-9227.2005 UR - http://dx.doi.org/10.1128/JVI.79.14.9217-9227.2005 ER - TY - JOUR AU - Pope, M. AU - Haase, A. T. TI - Transmission, acute HIV-1 infection and the quest for strategies to prevent infection JA - Nature Med. PY - 2003/// VL - 9 SP - 847 EP - 852 M3 - 10.1038/nm0703-847 N1 - 10.1038/nm0703-847 UR - http://dx.doi.org/10.1038/nm0703-847 ER - TY - JOUR AU - Ketas, T. J. TI - Entry inhibitors SCH-C, RANTES, and T-20 block HIV type 1 replication in multiple cell types JA - AIDS Res. Hum. Retroviruses PY - 2003/// VL - 19 SP - 177 EP - 186 M3 - 10.1089/088922203763315678 N1 - 10.1089/088922203763315678 UR - http://dx.doi.org/10.1089/088922203763315678 ER - TY - JOUR AU - Wang, T. TI - Discovery of 4-Benzoyl-1-[(4-methoxy-1H-pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2-(R)-methylpiperazine (BMS-378806): A novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions JA - J. Med. Chem. PY - 2003/// VL - 46 SP - 4236 EP - 4239 M3 - 10.1021/jm034082o N1 - 10.1021/jm034082o UR - http://dx.doi.org/10.1021/jm034082o ER - TY - JOUR AU - Ji, H. AU - Bracken, C. AU - Lu, M. TI - Buried polar interactions and conformational stability in the simian immunodeficiency virus (SIV) gp41 core JA - Biochemistry PY - 2000/// VL - 39 SP - 676 EP - 685 M3 - 10.1021/bi991893e N1 - 10.1021/bi991893e UR - http://dx.doi.org/10.1021/bi991893e ER -